You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

Article metrics

Article menu

Download PDFPDF

Letter
Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

 

Online download statistics by month:

Online download statistics by month: March 2023 to July 2025

AbstractFullPdf
Mar 2023030173
Apr 2023011819
May 2023010717
Jun 20230819
Jul 202306214
Aug 2023011615
Sep 202307110
Oct 202308317
Nov 202305713
Dec 202304112
Jan 202404011
Feb 202403316
Mar 202405040
Apr 202402212
May 202404123
Jun 202405315
Jul 202403916
Aug 202402813
Sep 202401610
Oct 202403610
Nov 202403712
Dec 202402226
Jan 202503826
Feb 202504910
Mar 202502113
Apr 202504219
May 202503221
Jun 20250318
Jul 2025010
Total01668500